Qianming Chen Selected Research

HMGN2 Protein (HMGN2)

4/2018	Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.
4/2018	HMGN2: An Antitumor Effector Molecule of γδT Cells.
4/2014	HMGN2 protein inhibits the growth of infected T24 cells in vitro.
1/2014	Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qianming Chen Research Topics

Disease

85	Neoplasms (Cancer) 04/2024 - 09/2002
50	Squamous Cell Carcinoma of Head and Neck 04/2024 - 12/2003
21	Oral Lichen Planus 03/2024 - 02/2008
15	Inflammation (Inflammations) 03/2024 - 05/2013
14	Carcinogenesis 12/2023 - 08/2003
14	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2003
13	Periodontitis 03/2024 - 07/2014
11	Infections 04/2024 - 05/2014
11	Mouth Neoplasms (Oral Cancer) 12/2023 - 05/2011
9	Oral Leukoplakia 10/2022 - 09/2008
7	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024 - 09/2014
7	Pain (Aches) 09/2023 - 10/2006
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 03/2004
6	Wounds and Injuries (Trauma) 01/2024 - 01/2022
5	Oral Submucous Fibrosis 12/2023 - 05/2011
5	Bites and Stings (Sting) 01/2022 - 01/2018
5	Carcinoma (Carcinomatosis) 01/2020 - 06/2011
4	Bacterial Infections (Bacterial Infection) 11/2023 - 05/2014
4	Hyperglycemia 11/2023 - 01/2021
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2015
4	Uveal melanoma 01/2019 - 01/2013
3	Peri-Implantitis 03/2024 - 11/2021
3	Disease Progression 01/2023 - 06/2008
3	Adenoid Cystic Carcinoma (Cylindroma) 09/2022 - 10/2014
3	Chronic Periodontitis 01/2019 - 06/2013
3	Osteoarthritis 01/2019 - 06/2013
3	Bone Resorption 01/2019 - 02/2012
3	Pemphigus (Pemphigus Vulgaris) 09/2016 - 04/2015
2	Dysbiosis 01/2024 - 01/2022
2	Precancerous Conditions 12/2023 - 05/2013
2	Erythema 11/2023 - 10/2006
2	Ulcer 11/2023 - 05/2009
2	Root Resorption 09/2023 - 09/2023

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2003
16	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2008
16	CytokinesIBA 01/2023 - 02/2008
8	HydrogelsIBA 11/2023 - 01/2012
7	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 05/2014
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 02/2008
6	AntigensIBA 01/2023 - 05/2013
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
5	AntibodiesIBA 01/2024 - 10/2020
5	Interleukin-6 (Interleukin 6)IBA 05/2023 - 01/2007
5	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2014
5	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2010
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2018
5	InterleukinsIBA 01/2016 - 04/2012
4	Interleukin-17 (Interleukin 17)IBA 01/2024 - 06/2013
4	Circular RNAIBA 12/2023 - 01/2018
4	CollagenIBA 11/2023 - 01/2022
4	Messenger RNA (mRNA)IBA 10/2023 - 09/2008
4	Therapeutic UsesIBA 10/2022 - 01/2012
4	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2022 - 07/2015
4	Cadherins (E-Cadherin)IBA 09/2022 - 03/2004
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 11/2020
4	Interferon Type IIBA 01/2022 - 01/2018
4	HMGN2 Protein (HMGN2)IBA 04/2018 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2017
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
3	VaccinesIBA 01/2024 - 01/2018
3	Monoclonal AntibodiesIBA 12/2023 - 06/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 12/2020
3	TabletsIBA 11/2022 - 10/2006
3	LigandsIBA 10/2022 - 06/2015
3	InflammasomesIBA 06/2022 - 01/2021
3	Receptors for Activated C KinaseIBA 01/2020 - 04/2012
3	MTOR InhibitorsIBA 01/2019 - 09/2014
3	GTP-Binding Proteins (G-Protein)IBA 01/2019 - 01/2013
3	Interleukin-10 (Interleukin 10)IBA 03/2017 - 07/2009
3	GlucocorticoidsIBA 09/2016 - 01/2014
3	Interleukin-23 (Interleukin 23)IBA 09/2015 - 06/2013
3	SaponinsIBA 01/2014 - 03/2013
3	amlexanox (Aphthasol)FDA Link 05/2012 - 10/2006
2	Glutamine (L-Glutamine)FDA Link 04/2024 - 01/2019
2	SolutionsIBA 03/2024 - 01/2012
2	Claudin-1IBA 03/2024 - 08/2021
2	Hyaluronic Acid (Hyaluronan)IBA 01/2024 - 08/2023
2	InterferonsIBA 01/2024 - 01/2022
2	Drinking WaterIBA 12/2023 - 09/2017
2	AntioxidantsIBA 09/2023 - 09/2023
2	MXeneIBA 06/2023 - 09/2022
2	Interferon-gamma (Interferon, gamma)IBA 01/2023 - 06/2009
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2014
2	Antifungal AgentsIBA 11/2022 - 01/2022
2	PolymersIBA 10/2022 - 01/2022
2	Cell-Free Nucleic AcidsIBA 10/2022 - 01/2022
2	Small Cytoplasmic RNAIBA 10/2022 - 01/2022
2	Photosensitizing Agents (Photosensitizers)IBA 09/2022 - 04/2022
2	Protein Kinases (Protein Kinase)IBA 09/2022 - 01/2021

Therapy/Procedure

24	Therapeutics 01/2023 - 09/2008
12	Immunotherapy 01/2024 - 11/2017
7	Oral Medicine 08/2023 - 03/2010
5	Photochemotherapy (Photodynamic Therapy) 08/2023 - 11/2020
5	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
4	Radiotherapy 12/2022 - 01/2018
2	Ligation 03/2024 - 10/2022
2	Photothermal Therapy 12/2023 - 06/2023
2	Orthodontics 09/2023 - 09/2023
2	Low-Level Light Therapy (LLLT) 09/2023 - 09/2023
2	Lasers (Laser) 09/2022 - 02/2019